Sun Pharmaceuticals | SUNP - Selling And Administration Expenses

Stock Price
1,770.90
Daily Change
-30.70 -1.70%
Monthly
3.13%
Yearly
3.91%
Q1 Forecast
1,766.47

Sun Pharmaceuticals reported INR24.89B in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.62B 252M Jun/2025
Bharat Petroleum INR 8.66B 88.2M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Jiangsu Hengrui CNY 3.23B 111.82M Sep/2025
Sh Fosun Pharma CNY 3.12B 22.02M Sep/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025